Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
High-Volume Hemodiafiltration is used for the first time in seven out of 10 CCINSHAE centers in Mexico In Mexico, 240 CCINSHAE patients are now being treated; more than 410 regular patients also treat
FMS Stock Likely to Gain on New Optimization Plan FME Reignite
09:21am, Tuesday, 24'th Jun 2025
Fresenius Medical Care unveils FME Reignite, targeting one billion euros in cost savings, tech upgrades and enhanced shareholder returns.
FMS or RXST: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 18'th Jun 2025
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or RxSight, Inc. (RXST). But which of these two companies is the best option for those lo
Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency
01:21pm, Tuesday, 17'th Jun 2025
Fresenius Medical Care AG FMS on Tuesday introduced a strategic roadmap — FME Reignite — aimed at revitalizing its core business, driving innovation and reshaping its organizational culture.
Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs
08:56am, Tuesday, 17'th Jun 2025
EXCLUSIVE: The dialysis company believes the impact of the treatments on its own performance will be ‘neutral to positive' rather than negative.
FME Reignite sets the ambition to lead kidney care through exceptional patient care and innovation The Company will set the new standard of care in the U.S. with the introduction of the 5008X dialysis
Fresenius Medical Care announces 1 bln euros share buyback programme
04:08am, Tuesday, 17'th Jun 2025
The world's largest dialysis specialist Fresenius Medical Care said, ahead of its capital markets day on Tuesday, that it plans to embark on a 1 billion euros ($1.16 billion) share buyback programme.
Focus Graphite Achieves 5N Purity from Lac Knife Graphite, Refined to Nuclear-Grade Purity Levels in AETC Testing
07:57am, Thursday, 12'th Jun 2025
Thermal purification run on Lac Knife concentrate material produced and characterized by AETC has resulted in 99.9992 wt. % C purity – laying the foundation for the transition into the nuclear spec
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
01:35pm, Wednesday, 04'th Jun 2025
FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.
Fresenius (FMS) Upgraded to Buy: Here's Why
01:01pm, Wednesday, 04'th Jun 2025
Fresenius (FMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Updated 5008X CAREsystem with Additional Features Receives FDA 510(k) Clearance Company announces first wave of Fresenius Kidney Care clinics in the U.S. to begin offering high-volume hemodiafiltr
Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025
08:00am, Friday, 30'th May 2025
Key abstract presentations showcase significant advancements in clinical care, artificial intelligence, and fluid management, demonstrating Fresenius Medical Care's commitment to improving patient out
Shareholders approved the proposed dividend of 1.44 Euro per share, representing a 21 percent increase year-over-year and marking the highest dividend in the company's history Excellent progress in th
Here's Why Fresenius (FMS) is a Strong Value Stock
10:46am, Thursday, 22'nd May 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Fresenius (FMS) is a Great Momentum Stock: Should You Buy?
01:00pm, Thursday, 15'th May 2025
Does Fresenius (FMS) have what it takes to be a top stock pick for momentum investors? Let's find out.
